- Home
- WBI vs MLTX Comparison
WBI vs MLTX Comparison
Compare WBI & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WBI | MLTX |
|---|---|---|
| Founded | 2016 | 2021 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Oilfield Services/Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 940.1M | 1.1B |
| IPO Year | 2025 | N/A |
Fundamental Metrics
Financial Performance| Metric | WBI | MLTX |
|---|---|---|
| Price | $23.01 | $15.48 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 9 |
| Target Price | ★ $27.25 | $22.22 |
| AVG Volume (30 Days) | 519.3K | ★ 2.3M |
| Earning Date | 03-16-2026 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $733,296,000.00 | N/A |
| Revenue This Year | $21.70 | N/A |
| Revenue Next Year | $12.32 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $18.64 | $5.95 |
| 52 Week High | $27.12 | $62.75 |
Technical Indicators
Market Signals| Indicator | WBI | MLTX |
|---|---|---|
| Relative Strength Index (RSI) | 56.10 | 48.42 |
| Support Level | $21.46 | $14.47 |
| Resistance Level | $22.52 | $16.69 |
| Average True Range (ATR) | 0.87 | 0.86 |
| MACD | 0.01 | -0.23 |
| Stochastic Oscillator | 38.46 | 25.69 |
Price Performance
Historical ComparisonAbout WBI WaterBridge Infrastructure LLC Class A Shares Representing Limited Liability Company Interests
WaterBridge Infrastructure LLC is integrated, pure-play water infrastructure company with operations predominantly in the Delaware Basin, the prolific oil and natural gas basin in North America. It operates the largest produced water infrastructure network in the United States through which it provides water management solutions to oil and natural gas E&P companies under long-term contracts, which include gathering, transporting, recycling and handling produced water. It also operate two energy waste management facilities for the disposal of non-hazardous waste resulting from oil and gas E&P activities, branded under Desert Environmental. The transportation, treatment and handling of produced water is crucial to oil and natural gas production.
About MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.